JP2017537126A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537126A5 JP2017537126A5 JP2017530728A JP2017530728A JP2017537126A5 JP 2017537126 A5 JP2017537126 A5 JP 2017537126A5 JP 2017530728 A JP2017530728 A JP 2017530728A JP 2017530728 A JP2017530728 A JP 2017530728A JP 2017537126 A5 JP2017537126 A5 JP 2017537126A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- small cell
- lung cancer
- cell lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410749394.0 | 2014-12-09 | ||
| CN201410749394 | 2014-12-09 | ||
| PCT/CN2015/096777 WO2016091168A1 (zh) | 2014-12-09 | 2015-12-09 | 抗非小细胞肺癌的喹啉衍生物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537126A JP2017537126A (ja) | 2017-12-14 |
| JP2017537126A5 true JP2017537126A5 (https=) | 2020-03-05 |
| JP6865684B2 JP6865684B2 (ja) | 2021-04-28 |
Family
ID=56106719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017530728A Active JP6865684B2 (ja) | 2014-12-09 | 2015-12-09 | 非小細胞肺癌に対するキノリン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10307412B2 (https=) |
| EP (1) | EP3231797B1 (https=) |
| JP (1) | JP6865684B2 (https=) |
| CN (1) | CN107001326B (https=) |
| AU (1) | AU2015360095B2 (https=) |
| ES (1) | ES2793286T3 (https=) |
| WO (1) | WO2016091168A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311029A (zh) | 2014-06-06 | 2016-02-10 | 正大天晴药业集团股份有限公司 | 抗肿瘤活性的喹啉衍生物 |
| CN105311030B (zh) * | 2014-06-06 | 2020-03-24 | 正大天晴药业集团股份有限公司 | 用于抗肿瘤的螺取代化合物 |
| US10307412B2 (en) | 2014-12-09 | 2019-06-04 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Quinoline derivative against non-small cell lung cancer |
| US9751859B2 (en) | 2015-05-04 | 2017-09-05 | Advenchen Pharmaceuticals, LLC | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts |
| CN114805352B (zh) | 2015-07-11 | 2023-09-15 | 南京爱德程医药科技有限公司 | 作为pi3k/mtor抑制剂的吡咯并吡啶取代的稠合喹啉化合物 |
| CN107296811B (zh) | 2016-04-15 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 一种用于治疗胃癌的喹啉衍生物 |
| CN115057815A (zh) | 2018-03-02 | 2022-09-16 | 正大天晴药业集团股份有限公司 | 作为c-Met激酶抑制剂的化合物的结晶及其制备方法和用途 |
| WO2019223672A1 (zh) * | 2018-05-22 | 2019-11-28 | 正大天晴药业集团股份有限公司 | 用于治疗非小细胞肺癌的喹啉衍生物 |
| JP7455806B2 (ja) * | 2018-07-18 | 2024-03-26 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | キノリン誘導体と抗体による薬物の組み合わせ |
| CN112638385B (zh) * | 2018-09-18 | 2023-03-31 | 正大天晴药业集团股份有限公司 | 用于治疗脑肿瘤的喹啉衍生物 |
| CN117085017A (zh) * | 2018-09-18 | 2023-11-21 | 正大天晴药业集团股份有限公司 | 用于治疗小细胞肺癌的喹啉衍生物 |
| CN113518621A (zh) * | 2019-03-07 | 2021-10-19 | 南京爱德程医药科技有限公司 | 按顺序使用卡奎替尼(安罗替尼)和标准化学疗法或免疫疗法的组合以治疗癌症 |
| CA3133141A1 (en) * | 2019-03-15 | 2020-09-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Combined pharmaceutical composition for treating small cell lung cancer |
| CN112274511B (zh) * | 2019-07-22 | 2024-04-02 | 正大天晴药业集团股份有限公司 | 用于治疗移植物抗宿主病的喹啉衍生物 |
| PH12022550721A1 (en) * | 2019-09-25 | 2024-05-13 | Debiopharm Int Sa | Dosing regimens for treatment of patients with locally advanced squamous cell carcinoma |
| CN114761010B (zh) * | 2019-11-25 | 2024-04-16 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物或其盐的联用药物组合物及其用途 |
| CN114929225B (zh) * | 2020-01-19 | 2024-06-28 | 正大天晴药业集团股份有限公司 | 用于治疗类风湿性关节炎的喹啉衍生物 |
| CN120154618B (zh) * | 2025-05-15 | 2025-11-18 | 正大天晴药业集团股份有限公司 | 格索雷塞用于治疗肺癌的用途或其药物组合物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| AU2008218806B2 (en) | 2007-02-20 | 2011-12-01 | Novartis Ag | Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| US8163923B2 (en) | 2007-03-14 | 2012-04-24 | Advenchen Laboratories, Llc | Spiro substituted compounds as angiogenesis inhibitors |
| US8148532B2 (en) * | 2007-03-14 | 2012-04-03 | Guoqing Paul Chen | Spiro substituted compounds as angiogenesis inhibitors |
| US20110212053A1 (en) | 2008-06-19 | 2011-09-01 | Dapeng Qian | Phosphatidylinositol 3 kinase inhibitors |
| IT1393351B1 (it) | 2009-03-16 | 2012-04-20 | Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa | Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi |
| CN102344438B (zh) * | 2010-08-01 | 2014-02-19 | 正大天晴药业集团股份有限公司 | 喹啉衍生物的结晶及其制备方法 |
| EP2780341B1 (en) * | 2011-11-14 | 2019-02-13 | Chia Tai Tianqing Pharmaceutical Group Co.,Ltd | Kinase modulating compounds, compositions containing the same and use thereof |
| JP2016506917A (ja) | 2013-01-18 | 2016-03-07 | アドヴェンチェン ファーマスーティカルズ，エルエルシー | 抗腫瘍剤６−（７−（（１−アミノシクロプロピル）メトキシ）−６−メトキシキノリン−４−イルオキシ）−ｎ−メチル−１−ナフトアミドおよびその結晶を調製するプロセス |
| CN104513229A (zh) * | 2013-09-28 | 2015-04-15 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物及其制备方法 |
| CN105311030B (zh) | 2014-06-06 | 2020-03-24 | 正大天晴药业集团股份有限公司 | 用于抗肿瘤的螺取代化合物 |
| CN105311029A (zh) | 2014-06-06 | 2016-02-10 | 正大天晴药业集团股份有限公司 | 抗肿瘤活性的喹啉衍生物 |
| AU2015290007B2 (en) | 2014-07-14 | 2019-11-21 | Advenchen Pharmaceuticals, Nanjing Ltd. | Fused quinoline compunds as pi3k, mTor inhibitors |
| US10307412B2 (en) | 2014-12-09 | 2019-06-04 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Quinoline derivative against non-small cell lung cancer |
| US9751859B2 (en) | 2015-05-04 | 2017-09-05 | Advenchen Pharmaceuticals, LLC | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts |
| CN114805352B (zh) | 2015-07-11 | 2023-09-15 | 南京爱德程医药科技有限公司 | 作为pi3k/mtor抑制剂的吡咯并吡啶取代的稠合喹啉化合物 |
| CN107296811B (zh) | 2016-04-15 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 一种用于治疗胃癌的喹啉衍生物 |
-
2015
- 2015-12-09 US US15/533,873 patent/US10307412B2/en active Active
- 2015-12-09 EP EP15867543.9A patent/EP3231797B1/en active Active
- 2015-12-09 AU AU2015360095A patent/AU2015360095B2/en active Active
- 2015-12-09 JP JP2017530728A patent/JP6865684B2/ja active Active
- 2015-12-09 WO PCT/CN2015/096777 patent/WO2016091168A1/zh not_active Ceased
- 2015-12-09 CN CN201580066275.8A patent/CN107001326B/zh active Active
- 2015-12-09 ES ES15867543T patent/ES2793286T3/es active Active
-
2019
- 2019-04-12 US US16/383,288 patent/US10888559B2/en active Active